Skip to main content

Quest PharmaTech: Top 10 Undervalued Biotechnology Industry Stocks (QPT)

AI-generated - The Globe and Mail - Sun Jul 13, 2025

Quest PharmaTech is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
QPTQuest PharmaTech0.040.120.08 (229.5%)118305.90.00.0
KNEKane Biotech0.050.090.04 (83.9%)1523096.70.00.0
RVXResverlogix0.040.080.03 (74.7%)4004012.70.00.0
MBXMicrobix Biosystems0.340.580.24 (70.5%)6550447.80.030.9
GSDDevonian Health Gr0.170.280.11 (66.2%)322325.20.00.0
VXLVaxil Bio0.230.370.14 (61.9%)26100.60.00.0
MDNAMedicenna Therapeutics0.951.470.52 (54.6%)3580174.10.00.0
MRVLMarvel Biosciences0.100.160.05 (49.4%)347784.70.00.0
CSCICosciens Biopharma4.807.102.30 (48.0%)160315.10.00.0
RKVRakovina Therapeutics0.060.080.02 (44.1%)5421914.50.00.0

All data provided as of July 13, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Quest PharmaTech

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Quest PharmaTech is listed under QPT on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.